Home > Riviste > Minerva Psichiatrica > Fascicoli precedenti > Minerva Psichiatrica 2020 March;61(1) > Minerva Psichiatrica 2020 March;61(1):17-9

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

ORIGINAL ARTICLE   

Minerva Psichiatrica 2020 March;61(1):17-9

DOI: 10.23736/S0391-1772.19.02034-X

Copyright © 2019 EDIZIONI MINERVA MEDICA

lingua: Inglese

Depression in women with lymphedema following treatment for breast cancer

Jose M. PEREIRA DE GODOY 1 , Maria de Fatima GUERREIRO GODOY 2

1 Department of Cardiovascular Surgery, School of Medicine, Sao Jose do Rio Preto (FAMERP), Sao Jose do Rio Preto, Brazil; 2 School of Medicine, Sao Jose do Rio Preto (FAMERP), Sao Jose do Rio Preto, Brazil



BACKGROUND: The aim of the present study was to evaluate the occurrence of depression in women with lymphedema following treatment for breast cancer.
METHODS: A cross-sectional study was conducted involving 32 consecutive patients with lymphedema stemming from breast cancer treatment. Women with lymphedema due to other causes were excluded. Depression was evaluated using the Beck Depression Inventory.
RESULTS: Among the 32 patients evaluated, 14 (43.75%) were without depression, 9 (28.12%) had mild to moderate depression and five (15.62%) had severe depression and 4 (12.5%) had extreme depression. Discussion: However, depression is limiting in every sense and can compromise treatment for lymphedema or adherence to cancer treatment. A psychiatric approach with the use of medications is therefore recommended as psychological support.
CONCLUSIONS: Depression is a frequent occurrence in women with lymphedema following treatment for breast cancer. Therefore, greater attention should be paid to this aspect in the routine evaluation of these patients.


KEY WORDS: Breast cancer lymphedema; Depression; Therapeutics

inizio pagina